Pathos AI vs Universal Health Services

Side-by-side comparison of AI visibility scores, market position, and capabilities

Universal Health Services leads in AI visibility (92 vs 53)
Pathos AI logo

Pathos AI

ChallengerHealthcare & Life Sciences

AI Oncology

Clinical-stage AI company raised $365M Series D at $1.6B for world's largest multimodal oncology AI; Novo Nordisk partnership; $467M total;

AI VisibilityBeta
Overall Score
C53
Category Rank
#1 of 1
AI Consensus
66%
Trend
up
Per Platform
ChatGPT
51
Perplexity
45
Gemini
50

About

Pathos AI is a clinical-stage AI company building the world's largest multimodal oncology AI platform, combining pathology imaging, genomics, clinical records, and treatment outcome data to power precision cancer care. Founded by oncologists, pathologists, and AI researchers, Pathos has assembled a dataset at a scale that gives its models a meaningful edge: by ingesting vast quantities of multimodal cancer data, its platform can predict treatment responses, identify biomarkers, and guide therapy selection with a level of accuracy that single-modality systems cannot match.\n\nThe platform serves oncologists and cancer centers by providing AI-augmented pathology reads, treatment outcome predictions, and clinical trial matching. Pathos's AI can analyze whole-slide pathology images in combination with molecular and clinical data to generate insights that inform diagnosis and treatment decisions. The company has also built partnerships with pharmaceutical companies — including Novo Nordisk and Prelude Therapeutics — to use its platform for drug development and clinical trial design, adding a biopharma revenue stream alongside its clinical business.\n\nPathos raised $365M in a Series D round at a $1.6B valuation, bringing total funding to $467M. The Series D was one of the largest oncology AI fundraises in history and included backing from top-tier life sciences investors. The Novo Nordisk and Prelude partnerships validate the platform's scientific depth and its utility across both clinical care and drug development. As of 2025–2026, Pathos is advancing toward direct clinical deployment and regulatory submissions, positioning itself as a core infrastructure layer for the future of AI-guided cancer treatment.

Full profile
Universal Health Services logo

Universal Health Services

LeaderHealthcare Tech

Hospital & Behavioral Health

Universal Health Services (UHS) reported ~$15.7B revenue in FY2024. Leading hospital and behavioral health facility operator with 350+ acute care and psychiatric hospitals in the U.S. HQ: King of Prussia, PA.

AI VisibilityBeta
Overall Score
A92
Category Rank
#1 of 1
AI Consensus
57%
Trend
stable
Per Platform
ChatGPT
83
Perplexity
98
Gemini
87

About

Universal Health Services, Inc. is one of the largest hospital and behavioral health facility operators in the United States, providing acute care hospital services, inpatient and outpatient behavioral health services, and specialized medical services. Founded in 1978 by Alan Miller, UHS operates approximately 350+ facilities — including general hospitals, surgical hospitals, freestanding emergency departments, and over 200 behavioral health centers treating mental illness and substance abuse disorders. The company operates across 37 states, Washington, D.C., and the United Kingdom.

Full profile

AI Visibility Head-to-Head

53
Overall Score
92
#1
Category Rank
#1
66
AI Consensus
57
up
Trend
stable
51
ChatGPT
83
45
Perplexity
98
50
Gemini
87
60
Claude
99
55
Grok
88

Key Details

Category
AI Oncology
Hospital & Behavioral Health
Tier
Challenger
Leader
Entity Type
brand
company

Capabilities & Ecosystem

Capabilities

Only Pathos AI
AI Oncology
Only Universal Health Services
Hospital & Behavioral Health

Integrations

Only Universal Health Services
Universal Health Services is classified as company.

Track AI Visibility in Real Time

Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.